Janumet and Glycosuria - a phase IV clinical study of FDA data

Summary:

Glycosuria is reported as a side effect among people who take Janumet (metformin hydrochloride; sitagliptin phosphate), especially for people who are male, 60+ old, also take Jardiance, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Glycosuria when taking Janumet. It is created by eHealthMe based on reports of 24,406 people who have side effects when taking Janumet from the FDA, and is updated regularly.

What is Janumet?

Janumet has active ingredients of metformin hydrochloride; sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 25,023 Janumet users. Check the latest studies of Janumet.

What is Glycosuria?

Glycosuria (excretion of glucose into the urine) is found to be associated with 241 drugs and 342 conditions by eHealthMe. Check the latest studies of Glycosuria.



On Jul, 13, 2026

24,406 people reported to have side effects when taking Janumet.
Among them, 12 people (0.05%) have Glycosuria.

Could Janumet cause Glycosuria?

Among these 12 people:

What is the gender of people who have Glycosuria when taking Janumet? *

  • female: 45.45 %
  • male: 54.55 %

What is the age of people who have Glycosuria when taking Janumet? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 10 %
  • 40-49: 20 %
  • 50-59: 20 %
  • 60+: 50 %

What are other drugs people take besides Janumet? *

  1. Gliclazide: 3 people, 25.00%
  2. Jardiance: 3 people, 25.00%
  3. Amlodipine: 2 people, 16.67%
  4. Xeljanz: 1 person, 8.33%
  5. Albuterol: 1 person, 8.33%
  6. Amaryl: 1 person, 8.33%
  7. Asa: 1 person, 8.33%
  8. Aspirin: 1 person, 8.33%
  9. Atenolol: 1 person, 8.33%
  10. Bydureon: 1 person, 8.33%

What are other side effects people have besides Glycosuria? *

  1. Blood Glucose Increased: 3 people, 25.00%
  2. Ketonuria (ketones in urine): 3 people, 25.00%
  3. Weight Decreased: 2 people, 16.67%
  4. High Blood Pressure: 2 people, 16.67%
  5. Fever: 2 people, 16.67%
  6. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 2 people, 16.67%
  7. Chronic Kidney Disease: 1 person, 8.33%
  8. Cough: 1 person, 8.33%
  9. Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 1 person, 8.33%
  10. Drug Ineffective: 1 person, 8.33%

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 3 people, 25.00%
  2. High Blood Pressure: 2 people, 16.67%
  3. Blood Pressure Abnormal: 2 people, 16.67%
  4. Thyroid Diseases: 1 person, 8.33%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
  6. Psoriasis (immune-mediated disease that affects the skin): 1 person, 8.33%
  7. Gout (uric acid crystals building up in the body): 1 person, 8.33%
  8. Gastritis (inflammation of stomach): 1 person, 8.33%
  9. Essential Hypertension (primary hypertension): 1 person, 8.33%
  10. Depression: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Janumet and have Glycosuria?

- Check whether Glycosuria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Janumet:

Glycosuria treatments and more:

How severe was Glycosuria and when was it recovered:

Expand to all the drugs that have ingredients of metformin hydrochloride; sitagliptin phosphate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Janumet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Glycosuria:

Browse all the conditions that are associated with Glycosuria:


How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride; sitagliptin phosphate (the active ingredients of Janumet) and Janumet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: